Market closed
SI-BONE/$SIBN
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About SI-BONE
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
Ticker
$SIBN
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
344
Website
SI-BONE Metrics
BasicAdvanced
$510M
Market cap
-
P/E ratio
-$0.91
EPS
1.23
Beta
-
Dividend rate
Price and volume
Market cap
$510M
Beta
1.23
52-week high
$21.70
52-week low
$11.76
Average daily volume
434K
Financial strength
Current ratio
8.252
Quick ratio
7.131
Long term debt to equity
22.626
Total debt to equity
23.359
Interest coverage (TTM)
-11.95%
Management effectiveness
Return on assets (TTM)
-11.54%
Return on equity (TTM)
-22.09%
Valuation
Price to revenue (TTM)
3.183
Price to book
3.08
Price to tangible book (TTM)
3.08
Price to free cash flow (TTM)
-19.819
Growth
Revenue change (TTM)
18.98%
Earnings per share change (TTM)
-22.88%
3-year revenue growth (CAGR)
21.73%
3-year earnings per share growth (CAGR)
-16.51%
What the Analysts think about SI-BONE
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for SI-BONE stock.
SI-BONE Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
SI-BONE Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
SI-BONE News
AllArticlesVideos
SI-BONE To Present at Piper Sandler 36th Annual Healthcare Conference on December 4, 2024
GlobeNewsWire·2 days ago
SI-BONE, Inc. (SIBN) Q3 2024 Earnings Call Transcript
Seeking Alpha·1 week ago
SI-BONE, Inc. Reports Financial Results for the Third Quarter 2024 and Updates Guidance
GlobeNewsWire·1 week ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for SI-BONE stock?
SI-BONE (SIBN) has a market cap of $510M as of November 22, 2024.
What is the P/E ratio for SI-BONE stock?
The price to earnings (P/E) ratio for SI-BONE (SIBN) stock is 0 as of November 22, 2024.
Does SI-BONE stock pay dividends?
No, SI-BONE (SIBN) stock does not pay dividends to its shareholders as of November 22, 2024.
When is the next SI-BONE dividend payment date?
SI-BONE (SIBN) stock does not pay dividends to its shareholders.
What is the beta indicator for SI-BONE?
SI-BONE (SIBN) has a beta rating of 1.23. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.